Cart
sales@molnova.com
PF-06882961
CAS No. 2230198-02-2
PF-06882961( —— )
Catalog No. M22917 CAS No. 2230198-02-2
PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 105 | In Stock |
|
| 5MG | 86 | In Stock |
|
| 10MG | 150 | In Stock |
|
| 25MG | 198 | In Stock |
|
| 50MG | 247 | In Stock |
|
| 100MG | 425 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-06882961
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.
-
DescriptionPF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGLP-1
-
Research AreaMetabolism
-
IndicationDiabetes Mellitus, Type 2
Chemical Information
-
CAS Number2230198-02-2
-
Formula Weight555.6
-
Molecular FormulaC31H30FN5O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (224.98 mM; Need ultrasonic)
-
SMILESOC(C1=CC=C(N=C(CN2CCC(C3=NC(OCC4=CC=C(C#N)C=C4F)=CC=C3)CC2)N5C[C@H]6OCC6)C5=C1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. 20th SCI/RSC Medicinal Chemistry Symposium.
molnova catalog
related products
-
MK-3577
A potent, oral active glucagon receptor antagonist blocking the glucagon effect for the treatment of T2DM.
-
GLP-1R Antagonist 1
GLP-1R Antagonist 1 is an orally active, CNS penetrant and non-competitive glucagon-like peptide 1 receptor (GLP-1R) antagonist (IC50: 650 nM).
-
Bay 55-9837
Selective VPAC2 receptor agonist (EC50 values are 0.4, 100 and >1000 nM for VPAC2, VPAC1 and PAC1, respectively in a cAMP accumulation assay; IC50 values are 60, 8700 and >10000 nM for VPAC2, VPAC1 and PAC1, respectively in a competition binding assay). Stimulates glucose-dependent insulin secretion in isolated human pancreatic islets. Reduces HIV-1 viral replication and shows cooperative effects when given in conjunction with VPAC1 agonists.
